Gender-neutral vaccination of children, aged 11-12, has been proven effective in preventing HPV and related cancers, including oropharyngeal, cervical, anal, vulvar, penile, and vaginal cancers.

Recommendations from trusted health care providers are one of the most effective interventions for preventing HPV infection and HPV-related cancers.